Exagen (XGN) Net Cash Flow (2018 - 2026)

Exagen has reported Net Cash Flow for 9 years, with the latest figure at -$10.7 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow rose 1.25% year-over-year to -$10.7 million; the trailing twelve-month figure through Mar 2026 stood at $10.3 million (up 164.2% YoY), and the FY2025 full-year result was $10.2 million, up 170.44% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$10.7 million, down from -$3.4 million in the prior quarter.
• The five-year high for Net Cash Flow was $18.8 million in Q2 2025, with the low at -$20.7 million in Q2 2023.
• Historically, Net Cash Flow has averaged -$4.6 million across 5 years, with a median of -$6.3 million in 2022.
• The largest YoY upside for Net Cash Flow was 775.72% in 2025 against a maximum downside of 343300.0% in 2025.
• Exagen's Net Cash Flow stood at -$6.3 million in 2022, then jumped by 227.44% to $8.0 million in 2023, then plunged by 99.99% to $1000.0 in 2024, then slumped by 343300.0% to -$3.4 million in 2025, then tumbled by 211.98% to -$10.7 million in 2026.
• The last three Net Cash Flow figures came in at -$10.7 million (Q1 2026), -$3.4 million (Q4 2025), and $5.6 million (Q3 2025), per Business Quant data.